Paid Clinical Trials Lubbock

Discover 91 paid clinical trials in Lubbock, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 91

Observational StudyRegistry of Avance® Nerve Graft's Utilization and Recovery Outcomes Post Peripheral Nerve Reconstruction

Recruiting

Sponsor:

Axogen Corporation

Location:

Lubbock TX, Fort Worth TX, Dallas TX, Richardson TXshow 33 more

Code:

NCT01526681

Conditions

Peripheral Nerve Injuries

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Processed Human Nerve Graft

Standard Treatment, Autogenous Nerve Graft, Direct Suture, etc.

Autogenous Nerve Graft

Nerve Tube Conduit

Autologous Breast Reconstruction with Neurotization

Talquetamab, Daratumumab, PomalidomideA Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Multiple Myeloma That Returns After Treatment or is Resistant to Treatment

Recruiting

PHASE3

Sponsor:

Janssen Research & Development, LLC

Location:

Lubbock TX, Houston TX, Tucson AZ, Westwood KSshow 29 more

Code:

NCT05455320

Conditions

Relapsed or Refractory Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Talquetamab

Daratumumab

Pomalidomide

Dexamethasone

PegozaferminA Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

Recruiting

PHASE3

Sponsor:

89bio, Inc.

Location:

Lubbock TX, Fort Worth TX, Farmers Branch TX, Albuquerque NMshow 89 more

Code:

NCT06419374

Conditions

Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Pegozafermin

Placebo

Chemotherapy with Endocrine TherapyEvaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Recruiting

PHASE3

Sponsor:

NRG Oncology

Location:

Lubbock TX, Amarillo TX, Lawton OK, Oklahoma City OKshow 715 more

Code:

NCT05879926

Conditions

Breast Cancer

Eligibility Criteria

Sex: Female

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

Ovarian Function Suppression + Aromatase Inhibitor

Adjuvant Chemotherapy + Ovarian Function Suppression

Selumetinib vs. Carboplatin/VincristineA Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma

Recruiting

PHASE3

Sponsor:

National Cancer Institute (NCI)

Location:

Lubbock TX, Fort Worth TX, Oklahoma City OK, Albuquerque NMshow 104 more

Code:

NCT03871257

Conditions

Low Grade Glioma

Neurofibromatosis Type 1

Visual Pathway Glioma

Eligibility Criteria

Sex: All

Age: 2 - 21

Healthy Volunteers: Not accepted

Interventions

Carboplatin

Magnetic Resonance Imaging

Quality-of-Life Assessment

Questionnaire Administration

Selumetinib Sulfate

Epcoritamab & Anti-NeoplasticsA Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma

Recruiting

PHASE2

Sponsor:

Genmab

Location:

Lubbock TX, Tucson AZ, Kansas City MO, Atlanta GAshow 13 more

Code:

NCT05283720

Conditions

Non-Hodgkin Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Epcoritamab

Lenalidomide

Ibrutinib

Rituximab

Cyclophosphamide

Thrombin Receptor AntagonistExcellence In Peripheral Artery Disease Thrombin Receptor Antagonist Intervention In Claudication Evaluation (XLPAD-TRACE Trial)

Recruiting

Sponsor:

North Texas Veterans Healthcare System

Location:

Lubbock TX, Oklahoma City OK, Dallas TX, Denver COshow 7 more

Code:

NCT02660866

Conditions

Peripheral Arterial Disease

Eligibility Criteria

Sex: All

Age: 40 - 70+

Healthy Volunteers: Not accepted

Interventions

Placebo + background APT + SMT

Vorapaxar 2.08 mg/d + background APT + SMT.

Anti-obesity MedicationStudy of Patients Being Treated With Anti-obesity Medication

Recruiting

Sponsor:

Texas Tech University

Location:

Lubbock TX

Code:

NCT06790160

Conditions

Obesity and Overweight

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

SonelokimabEvaluation of Sonelokimab in Patients With Active Psoriatic Arthritis Naive to Biologic Disease-Modifying Antirheumatic Drug

Recruiting

PHASE3

Sponsor:

MoonLake Immunotherapeutics AG

Location:

Lubbock TX, Colleyville TX, Plano TX, Allen TXshow 21 more

Code:

NCT06641076

Conditions

Arthritis, Psoriatic

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Sonelokimab

Placebo

Serplulimab & ChemotherapyTo Evaluate Efficacy and Safety of Serplulimab + Chemotherapy (Carboplatin- Etoposide) in US Patients With ES-SCLC

Recruiting

PHASE3

Sponsor:

Shanghai Henlius Biotech

Location:

Lubbock TX, Fort Worth TX, Santa Fe NM, Wichita KSshow 85 more

Code:

NCT05468489

Conditions

Extensive Stage Small Cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Serplulimab + chemotherapy (carboplatin-etoposide)

Atezolizumab + chemotherapy (carboplatin-etoposide)